Toggle navigation
Toggle navigation
化学合成
生命科学
分析化学与色谱
结构式检索
分类目录
价格折扣
Excel/SDF文件处理
×
搜索结果
MolSoft
Ketcher
ChemDraw
同时返回
精确结构检索
、
子结构(亚结构)检索
、
相似结构检索
结果。
同时返回
精确结构检索
、
子结构(亚结构)检索
、
相似结构检索
结果。
同时返回
精确结构检索
、
子结构(亚结构)检索
、
相似结构检索
结果。
显示chemdraw
Medical Research Areas
NF-kB
Akt
Akt
下级目录
APcK110
[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol
R428
AT13148
(2S)-N1-[4-Methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-1,2-pyrrolidinedicarboxamide
BAY1082439
AZD8186
4-Amino-5,6,7,8-tetrahydro-5-oxo-8-(β-D-ribofuranosyl)pyrido[2,3-d]pyrimidine-6-carboxamide
Insulin-likeGrowthFactor-1ReceptorInhibitor
CID 9825149
A-443654
TYRPHOSTIN AG 490
N-[[(3S)-3-AMINO-1-(5-ETHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-3-PYRROLIDINYL]METHYL]-2,4-DIFLUORO-BENZAMIDE
目录项下的产品
1001083-74-4 / MFCD101083744
APcK110 is a novel Kit inhibitor . APcK110 inhibits proliferation of the mastocytosis cell line HMC1.2 and the SCF-responsive cell line OCI/AML3 in a dose-dependent manner . APcK110 is a more potent inhibitor of OCI/AML3 proliferation than the clinically used Kit inhibitors imatinib and dasatinib and at least as potent as cytarabine. APcK110 inhibits the phosphorylation of Kit, Stat3, Stat5, and Akt in a dose-dependent fashion, showing activity of APcK110 on Kit and its downstream signaling pathways . APcK110 may have potent application in AML.
原料
0
资源
0.0
询
0.0
%成交
交易量
试剂
1009298-09-2 / MFCD109298092
Azd-8055
[5-[2,4-二((3S)-3-甲基吗啉-4-基)吡啶并[2,3-D]嘧啶-7-基]-2-甲氧基苯基]甲醇
原料
0
资源
0.0
询
0.0
%成交
交易量
试剂
中华人民共和国
√
1037624-75-1 / MFCD137624751
(S)-1-(6,7-Dihydro-5H-Benzo[6,7]Cyclohepta[1,2-C]Pyridazin-3-Yl)-N3-(7-(Pyrrolidin-1-Yl)-6,7,8,9-Tetrahydro-5H-Benzo[7]Annulen-2-Yl)-1H-1,2,4-Triazole-3,5-Diamine
(S)-1-(6,7-二氢-5H-苯并[6,7]环庚并[1,2-c]哒嗪-3-基)-N3-(7-(吡咯烷-1-基)-6,7,8,9-四氢-5H-苯并[7]环庚烯-2-基)-1H-1,2,4-三唑-3,5-二胺
原料
0
资源
0.0
询
0.0
%成交
交易量
试剂
中华人民共和国
1056901-62-2 / MFCD156901622
AT13148 is a novel oral multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activity, which shows a distinct mechanism of action from other AKT inhibitors. AT13148 is currently being developed by Astex Pharmaceuticals. AT131148 was identified utilizing high-throughput X-ray crystallography and fragment-based lead discovery techniques. AT13148 caused substantial blockade of AKT, p70S6K, PKA, ROCK and SGK substrate phosphorylation and induction of apoptosis in both a concentration and time-dependent manner in cancer cells with clinically relevant genetic defects both in vitro and in vivo.
原料
0
资源
0.0
询
0.0
%成交
交易量
试剂
1217486-61-7 / MFCD317486617
Alpelisib, also known as BLY719, is an orally bioavailable phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity. PI3K inhibitor BYL719 specifically inhibits PIK3 in the PI3K/AKT kinase (or protein kinase B) signaling pathway, thereby inhibiting the activation of the PI3K signaling pathway. This may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations. Activation of the PI3K signaling pathway is frequently associated with tumorigenesis. Dysregulated PI3K signaling may contribute to tumor resistance to a variety of antineoplastic agents. Check for active clinical trials or closed clinical trials using this agent.
(2S)-N1-[4-甲基-5-[2-(2,2,2-三氟-1,1-二甲基乙基)-4-吡啶基]-2-噻唑基]-1,2-吡咯烷二甲酰胺
原料
0
资源
0.0
询
0.0
%成交
交易量
试剂
中华人民共和国
√
1375469-38-7 / MFCD475469387
BAY1082439 is an orally bioavailable inhibitor of the class I phosphoinositide 3-kinase (PI3K) alpha and beta isoforms with potential antineoplastic activity. PI3K alpha/beta inhibitor BAY1082439 selectively inhibits both PI3K alpha, including mutated forms of PIK3CA, and PI3K beta in the PI3K/Akt/mTOR pathway, which may result in tumor cell apoptosis and growth inhibition in PI3K-expressing and/or PTEN-driven tumor cells. By specifically targeting class I PI3K alpha and beta, this agent may be more efficacious and less toxic than pan PI3K inhibitors.
原料
0
资源
0.0
询
0.0
%成交
交易量
试剂
1627494-13-6 / MFCD727494136
(R)-8-(1-((3,5-Difluorophenyl)Amino)Ethyl)-N,N-Dimethyl-2-Morpholino-4-Oxo-4H-Chromene-6-Carboxamide
(R)-8-(1-((3,5-二氟苯基)氨基)乙基)-N,N-二甲基-2-吗啉-4-氧代-4H-苯并吡喃-6-甲酰胺
原料
0
资源
0.0
询
0.0
%成交
交易量
试剂
36707-00-3 / MFCD36707003
4-Amino-5,6,7,8-tetrahydro-5-oxo-8-(β-D-ribofuranosyl)pyrido[2,3-d]pyrimidine-6-carboxamide
原料
0
资源
0.0
询
0.0
%成交
交易量
试剂
468740-43-4 / MFCD68740434
(S)-4-((2-(3-Chlorophenyl)-2-hydroxyethyl)amino)-3-(4-methyl-6-morpholino-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one
(S)-4-((2-(3-氯苯基)-2-羟乙基)氨基)-3-(4-甲基-6-吗啉-1H-苯并[d]咪唑-2-基)吡啶-2(1H)-酮
原料
0
资源
0.0
询
0.0
%成交
交易量
试剂
中华人民共和国
475488-23-4 / MFCD75488234
5-[3-(Phenylmethoxy)Phenyl]-7-[Trans-3-(1-Pyrrolidinylmethyl)Cyclobutyl]-7H-Pyrrolo[2,3-d]Pyrimidin-4-Amine
5-(3-苄氧基苯基)-7-[反式-3-[(吡咯烷-1-基)甲基]环丁基]-7H-吡咯并[2,3-D]嘧啶-4-胺
原料
0
资源
0.0
询
0.0
%成交
交易量
试剂
√
552325-16-3 / MFCD52325163
A-443654
原料
0
资源
0.0
询
0.0
%成交
交易量
试剂
133550-30-8 / MFCD00209833
(E)-N-Benzyl-2-Cyano-3-(3,4-Dihydroxyphenyl)Acrylamide
(E)-N-苄基-2-氰基-3-(3,4-二羟苯基)丙烯酰胺
原料
0
资源
0.0
询
0.0
%成交
交易量
试剂
√
1004990-28-6 / MFCD11846250
(S)-N-[[3-Amino-1-(5-ethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrrolidin-3-yl]methyl]-2,4-difluorobenzamide
原料
0
资源
0.0
询
0.0
%成交
交易量
试剂